Biolase Inc Reports Results For The Quarter Ended In December: Earnings Summary

November 26

28/03/2023 22:54

* BIOLASE Inc  BIOL.OQ  reported a quarterly adjusted loss
of
$1.28​​ per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for a loss
of 64 cents per share.
    * Revenue rose 13.3% to $14.05 million from a year ago;
analysts
expected $14.07 million. 
    * BIOLASE Inc's reported EPS for the quarter was a loss of
$1.28​.
    * The mean earnings estimate of analysts had fallen by
about 2.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * BIOLASE Inc shares had fallen by 42.5% this quarter.
    * The company reported a quarterly loss of $9.86 million.
    * Wall Street's median 12-month price target for BIOLASE Inc
is
$3.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 28 at 09:54 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.64          -1.28          Missed
 Sep. 30 2022      -0.84          -1.10          Missed
 Jun. 30 2022      -0.62          -0.91          Missed
 Mar. 31 2022      -0.68          -0.81          Missed